Quest Diagnostics Acquires Labtech Diagnostics

Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B

July 8, 2024

Healthcare Services

Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.

Discovery Life Sciences Acquires QualTek Molecular Laboratories

May 5, 2019

Healthcare Services

Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.

Calibre Scientific Acquires Labtech International Ltd

January 17, 2024

Medical Devices

Calibre Scientific has acquired Labtech International Ltd, a UK-based supplier and service provider of life science instruments, microscopy equipment, consumables and technical services. The acquisition expands Calibre Scientific's analytical instrument and service capabilities across the British Isles, strengthening its product offering and local service footprint for customers in biotechnology, diagnostics, education, environmental and pharmaceutical markets.

SSI Diagnostica (Adelis) Acquires TECHLAB, Inc. from Pharos Capital

August 22, 2022

Medical Devices

SSI Diagnostica, a portfolio company of Adelis Equity, has acquired TECHLAB, Inc. from Pharos Capital Group. The acquisition combines SSI Diagnostica's global distribution and production capabilities with TECHLAB's U.S. R&D and manufacturing to grow the combined diagnostics business; TECHLAB will continue operating from its Virginia facilities and retain its management team and workforce.

Quest Diagnostics Acquires Haystack Oncology

April 27, 2023

Healthcare Services

Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.

Medical Laboratory Diagnostics (MedLabs) Acquires Mercy Diagnostics

April 1, 2019

Healthcare Services

Caymus Equity Partners’ portfolio company Medical Laboratory Diagnostics, LLC (MedLabs) acquired Mercy Diagnostics, Inc., a Mount Laurel, New Jersey clinical diagnostics laboratory. The add-on transaction closed on April 24, 2019 and is MedLabs’ first strategic acquisition since the company’s majority recapitalization in March 2018.